RLMD · Relmada Therapeutics, Inc.
$4.80
+0.05 (+1.05%)
At close · Aug 14
Market Cap
$512.02M
Shares
106.67M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1553643
CUSIP
75955J402
13F (30d)
126 filings
124 filers
Visit website
Investor relations